Clinical trial
Phase I/II Study of An Ex Vivo Immunotherapy for Treatment of Idiopathic Aplastic Anemia
NCT00399971 is registered in ClinicalTrials.gov with Shenzhen Zhongxing Yangfan Biotech Co. Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I/II Study of An Ex Vivo Immunotherapy for Treatment of Idiopathic Aplastic Anemia
- Lead sponsor
- Shenzhen Zhongxing Yangfan Biotech Co. Ltd.
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- November 30, 2002
- Completion date
- December 31, 2009
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.